An international research collaboration led by University College Dublin (UCD), involving OncoMark, a spin-out company headquartered at NovaUCD, and the Bellvitge Biomedical Research Institute in Barcelona, has identified a set of biomarkers strongly linked with survival in patients with melanoma that may help clinicians with treatment decisions. The study, which was published recently in the journal BMC Medicine, has also identified several biomarkers of tumour development and progression that have never before been linked to melanoma of the skin. Cutaneous melanoma is the most life-threatening form of skin cancer with rising incidence and mortality rates particularly in men older than…
Login
Register